Johnson & Johnson has offered to pay up to $5.5 billion to settle lawsuits alleging that its talcum-based baby powder and other products cause ovarian cancer. The proposed settlement aims to resolve tens of thousands of cases currently pending in state and federal courts.
Landmark Settlement Aims to End Decades-Long Battle
Johnson & Johnson has denied the allegations, claiming that its talc-based products are safe and do not contain asbestos. The company has repeatedly stated that studies show talc does not cause cancer. In a statement, Erik Haas, J&J's vice president of litigation, said that the allegations are "meritless" and that the company is willing to settle in order to finally resolve the matter.
History of Lawsuits and Recent Court Rulings
Lawsuits against J&J over its talc-based baby powder started as early as 2009. In 2022, the company announced that it would stop making and selling its talc-based baby powder worldwide. This decision came after the company had ended sales of the product in the US more than two years earlier. In July, a federal court handed J&J a victory by questioning individual plaintiffs' ability to show that talc was the direct cause of their ovarian cancer.
Settlement Terms and Conditions
The proposed settlement would cover about 69,000 cases, totaling most of the remaining talc-related claims. The firm will offer up to $3 billion next year, with no additional payments due before 2028. The proposal must be accepted by legal firms representing 95% of the ovarian cancer claims in state and federal courts before it can be finalized. Haas stated that J&J is confident that it would have "ultimately prevailed with further litigation" just as it has in the majority of cases heard in court to date.
Background on Talc and Asbestos
Talc is a natural mineral made of magnesium, silicon, oxygen, and hydrogen, known for its soapy feel and is often used in baby powder. Talc is mined from the earth and is found in seams close to those of asbestos, which is a material known to cause cancer. J&J has repeatedly denied allegations that its talc products were contaminated with asbestos, which is a major concern in the lawsuits.
What Happens Next
The proposed settlement must be accepted by legal firms representing 95% of the ovarian cancer claims in state and federal courts before it can be finalized. If accepted, the settlement would bring an end to decades-long litigation and allow J&J to "put this matter behind it" and focus on its mission to develop medicines and devices that save lives. The company's announcement of the proposed settlement comes after a series of court victories and a shift in its business strategy, including the transition to an all-cornstarch-based baby powder portfolio.
Source: Joy Online
